Lotte Group's Shin stresses unlearning as key to innovation

Lotte is seeking a breakthrough as it faces a hostile business environment after credit downgrades of its affiliates

Lotte Group headquarters in Seoul
Lotte Group headquarters in Seoul
Hun-Hyoung Ha 1
2023-07-19 11:21:46 hhh@hankyung.com
Corporate strategy

Disregarding existing ways and being open to new opportunities are challenging in South Korea’s large conglomerates, where a strict corporate culture reigns.

But more often than not, unlearning before learning something new is the key to innovation.

Lotte Group Chairman Shin Dong-bin tried to drive this point home on Tuesday — that innovation comes from ditching old ways of doing things.

“Ignoring the rapidly changing business environment and stubbornly sticking to past successes won’t work any more. We must create our own ways of work that align with the current environment, through flexible thinking,” he said at a meeting of group affiliate executives called the Value Creation Meeting. “You cannot survive unless you try something new.”

The chairman urged a group of some 80 Lotte affiliate chief executives and division heads, including Lotte Corp. Vice Chairman Lee Dong-woo, to reassess their management strategies to ensure sustainable growth.

Lotte Group Chairman Shin Dong-bin
Lotte Group Chairman Shin Dong-bin

HEALTHCARE AND MOBILITY

He called on Lotte leaders to find new growth engines in the healthcare and mobility sectors.

Lotte Biologics Co. aims to become one of the top 10 biopharmaceutical contract development and manufacturing companies by 2030.

The company said earlier it will build multiple antibody drug plants with a combined production capacity of 360,000 liters by then.

It also plans to expand its investment in a US antibody drug conjugate (ADC) affiliate in Syracuse, New York, which it acquired from Bristol Myers Squibb last year.

Lotte Biologics' pharmaceuticals production plant in Syracuse, New York
Lotte Biologics' pharmaceuticals production plant in Syracuse, New York

Lotte Healthcare Co., which is powering the group’s health and wellness business, plans to open a one-stop healthcare service platform, dubbed Cazzle, in September.

Chairman Shin’s call for innovation comes after the credit ratings of several Lotte affiliates, including Lotte Chemical Corp., the group’s cash cow, were downgraded by a domestic ratings agency amid a worsening business climate last month.

Write to Hun-Hyoung Ha at hhh@hankyung.com
In-Soo Nam edited this article.

Lotte Energy Materials aspires to become copper foil leader: CEO

Lotte Energy Materials aspires to become copper foil leader: CEO

Lotte Energy Materials CEO Kim Yeon-seop unveils the company's business strategy South Korea’s Lotte Energy Materials Corp. said on Tuesday that growing demand for reasonably priced electric vehicles will expand the market for high-end copper foil, a key battery component, in which it aim

Lotte Rental drops plan to enter Korea’s secondhand car sales market

Lotte Rental drops plan to enter Korea’s secondhand car sales market

Lotte Rental CEO Choi Jin-hwan unveils the company's business plans during its CEO IR Day Lotte Rental Co., South Korea’s largest car rental firm, has dropped its plan to enter the domestic used car sales market. Instead, it will strengthen its used car rental and commercial vehicle leasi

Lotte affiliates’ credit ratings downgraded all at once

Lotte affiliates’ credit ratings downgraded all at once

Lotte Chemical Yoesu plant  The ratings of Lotte's subsidiaries have been downgraded en masse. Lotte Chemical Corp., the group's cash cow, was cut to AA from AA+.NICE Investors Service, the South Korean credit rating agency, lowered the ratings of Lotte Chemical, Lotte Corp., Lotte Rental

Lotte’s soju team applauded as MZers bedazzled by sugar-free Saero

Lotte’s soju team applauded as MZers bedazzled by sugar-free Saero

Lotte Chilsung's sugar-free soju Saero Young consumers, dubbed millennials and Gen Zers, are by nature conscious of fleeting fads.These days, one of the hottest trends in South Korea is healthy pleasure, managing health and enjoying fun at the same time.The alcoholic beverage industry is no exc

Lotte Biologics to invest additional $48 mn in US plant

Lotte Biologics to invest additional $48 mn in US plant

South Korea’s Lotte Biologics Co. held a plaque ceremony on Monday to commemorate the acquisition of a pharmaceutical production plant from Bristol Myers Squibb in Syracuse, New York, at the end of last year.Lotte Biologics plans to invest approximately $48 million in the Syracuse plant

(* comment hide *}